Navigation Links
Thoratec Reports a 19 Percent Increase in Annual Revenues as Cardiovascular Division Revenues Increase 30 Percent in 2009
Date:1/28/2010

net income per diluted share - - non-GAAP (2) 65,665 64,868 65,318 63,486 (1) Adjusted for the retrospective adoption of the accounting for convertible debt instruments that may be settled in cash upon conversion, including partial settlements, in accordance with ASC 470-20, Debt. (2) The company's total diluted share count on a non-GAAP basis for the three and twelve months ended January 3, 2009 and January 2, 2010 include approximately 7.3 million shares underlying its convertible notes as they were dilutive for the respective quarters.
    
    
    The following table reconciles the specific items excluded from GAAP gross
    profit and gross margin in the calculation of non-GAAP gross profit and 
    gross margin for the periods shown below:
    
                                  THORATEC CORPORATION
                       Reconciliation of GAAP to Non-GAAP Gross Profit
                                       (Unaudited)
                                      (in thousands)
    
                      Three Months Ended             Twelve Months Ended
                      ------------------             -------------------
                  January 2,      January 3,     January 2,         January 3,
                    2010            2009           2010               2009
                    ----            ----           ----               ----
    
    Gross
     profit
     on a
     GAAP
     basis      $61,320  58.7% $50,567  59.0%  $219,834  58.8%  $185,998 59.3%
       Share-
        based
        compen-
        sation
        expense     489            466            2,023            1,749
                    ---            ---            -----            -----
    Gross
     profit
     on a
     non-
     GAAP
     basis      $61,809  59.2% $51,033  59.6%  $221,857  59.3%  $187,747 59.9%
                =======        =======         ==
'/>"/>
SOURCE Thoratec Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine technology :

1. Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
2. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
3. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
4. Thoratec Announces Acquisition of Innovative Catheter-Based Heart Pump Technology
5. Thoratec Schedules Fiscal 2009 Year-End Conference Call, Webcast
6. Thoratec Presentation at Canaccord Adams Conference to be Webcast
7. Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy
8. Thoratec Investor Meeting to Review HeartMate II (R) Destination Therapy Trial Data to Be Webcast
9. Thoratec Presentation at Piper Jaffray Conference to be Webcast
10. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
11. Spherix Reports Second Quarter Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014  BC Technical, the largest nationwide, ... America , Inc., a leading provider of Siemens Nuclear ... long-term agreement naming BC Technical as the authorized provider ... MiE and BC Technical announced today that the ... BC Technical as the service and systems provider for ...
(Date:7/10/2014)... --  Ventana Medical Systems, Inc.  (Ventana), a member of ... an agreement with Merck KGaA, Darmstadt, Germany ... the United States and ... division on the development and commercialization of a companion ... diagnostic assays. In alignment with Merck KGaA,s strategic approach ...
(Date:7/10/2014)... Israel , July 10, 2014   ... Diabetes Management Solution, today announced the appointment of ... independent member of its Board of Directors. ... legal and business experience to LabStyle as an ... and legal and corporate governance expert. He currently ...
Breaking Medicine Technology:BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4
(Date:7/12/2014)... my mom’s stroke, she loss the use of her right side. ... his left side. Eating became a difficult task for them so ... enjoy eating again,” said an inventor, from Fayetteville, N.C. As a ... (P C H PLATE). , The PATRICIA CAROL HALL PLATE (P ... individuals who suffer from stroke, experience tremors or loss of movement. ...
(Date:7/12/2014)... New York (PRWEB) July 12, 2014 ... to move forward in U.S. courts, Bernstein Liebhard LLP ... elevated metal ion levels to the failure of metal-on-metal ... 2nd issue of The Journal of Bone & Joint ... received unilateral Articular Surface Replacement prostheses at least twelve ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 For those who ... bodies can readily absorb the nutrients in food. The enzymes ... that are small enough to be absorbed by human bodies. ... a lack of enzymes in regular food is the cause ... product that was started by Michelle DelPresto, a mother of ...
(Date:7/12/2014)... 2014 “Critical Care Therapeutics in ... Late-Stage Four-Factor PCCs and Recombinant Products to Drive ... care market in the US, UK, France, Germany, ... an estimation of market size for 2013, along ... care indications that are being treated using the ...
(Date:7/12/2014)... 2014 As reported in this July ... and Technology), the June 25th, 2014 Supreme Court ruling in ... world. It was also met with both cheers and ... it was seen from an individual privacy perspective, or a ... there is now precedent which will require law enforcement officials ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 2Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 3Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 4Health News:New Super Digestive Enzyme, DZ10, Supercharges The Digestion Process 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 3Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 4Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 5Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 6Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 2Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 3Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 4Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 5
... during college, survey shows , , MONDAY, July 7 (HealthDay ... common before and during college, a new study shows. ... (57.1 percent female) at three urban college campuses to ... , 407 (44.7 percent) of respondents said they experienced ...
... the risk seems bigger if certain painkillers are ... News) -- The widely prescribed class of antidepressants ... in the upper gastrointestinal tract, especially when taken ... study says. , Although reports of this effect ...
... Preserve Vital Stem Cells During, Their Menstrual Flow; Potential for Future Anti-Aging ... ... Fla., July 7 With today,s hectic,lifestyle, where most women are juggling ... a serious illness in,the future is not something that readily comes to ...
... HARRISBURG, Pa., July 7 Need to find ... area? Are you,a senior citizen living in Pennsylvania ... information on oral health topics such as,brushing and ... no,further! PDA,s website, http://www.padental.org, is an ...
... CCA Industries,Inc. (Amex: CAW ) declared today a ... shareholders of record as of August 1, 2008, payable on,September ... 31, 2008 were $17,389,985.,Net income was $790,692 and earnings per ... of $1,292,921 and earnings per,share of $0.18 fully diluted for ...
... In a New York City metro-area first, a 93-year-old ... at NewYork-Presbyterian Hospital, the only center on the Eastern ... new stent graft was implanted under an FDA-approved clinical ... a complex form of abdominal aortic aneurysms in which ...
Cached Medicine News:Health News:Relationship Violence Common Among College Students 2Health News:Popular Antidepressants Linked to GI Bleeding 2Health News:Popular Antidepressants Linked to GI Bleeding 3Health News:Taking Control: Future Therapies for a Host of Serious Diseases May Be Found in Women's Menstrual Blood 2Health News:Pennsylvania Dental Association Website: A Great Resource for Pennsylvania Residents 2Health News:CCA Industries, Inc. Declares Its Seventeenth Consecutive Dividend 2Health News:NYC first: Complex aneurysm treated using new fenestrated endograft stent 2
... Combines BchiVac V-500 with Vacuum ... Efficiently controls vacuum levels from ... pump designed to handle most vacuum applications. ... up to two rotary evaporators Laboratory ...
... Combines BchiVac V-500 with Vacuum Controller V-800 ... mechanism turns V-500 on and off as needed to ... is a powerful PTFE membrane vacuum pump designed to ... suited for use with up to two rotary evaporators ...
Universal vacuum pump (capacity 34 L/min, 8 mbar vacuum abs.)...
... a new addition to the powerful PTFE membrane ... pump can achieve an ultimate vacuum of 1 ... Applications For use with vacuum ... Distillation applications from lab size up to industrial ...
Medicine Products: